Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate has 12 known drug interactions based on U.S. FDA drug labeling data. 8 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Centrally Acting Drugs, Corticosteroids, Diazoxide. Patients taking Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 12
- Major
- 8
- Moderate
- 4
Major (8)
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Centrally Acting Drugs— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Corticosteroids— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Diazoxide— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Guanethidine— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Hydralazine— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Methyldopa— Concurrent use with sodium phosphate may result in hypernatremia.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Potassium Supplements— May cause hyperkalemia. Periodic serum potassium level determinations recommended.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Repository Corticotropin— Concurrent use with sodium phosphate may result in hypernatremia.
Moderate (4)
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Antacids Containing Aluminum— May bind phosphate and prevent its absorption.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Antacids Containing Magnesium— May bind phosphate and prevent its absorption.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Calcium Antagonists— May bind phosphate and prevent its absorption.
- Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate + Vitamin D— May antagonize the effects of phosphates in treatment of hypercalcemia.